je.st
news
Sunovion Pharmaceuticals Inc. And Afraxis, Inc. Announce Novel Drug Discovery Partnership
2013-09-04 07:19:53| drugdiscoveryonline News Articles
Sunovion Pharmaceuticals Inc. (Sunovion) and Afraxis, Inc. recently announced that they have signed a partnership agreement to utilize the unique Enhanced Spine Platform (ESP) developed by Afraxis, Inc. to accelerate Sunovion’s preclinical central nervous system (CNS) drug discovery process
Tags: drug
partnership
discovery
announce
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||